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Stability indicating methodAbstract Clonazepam contains one benzodiazepine ring in its chemical structure which makes it
vulnerable to degradation. In this study, green analytical chemistry approach was applied in
attempts for the development of validated stability indicating RP-HPLC method for determining
clonazepam and its related substances in pharmaceutical formulation. Validation has been per-
formed according to ICH guidelines. Assay was capable of simultaneous monitoring of the intact
drug in the presence of its related substances within the same run. HPLC assay involved an ODS
column and a mobile phase composed of 2% sodium dodecyl sulfate, 0.05 M sodium acetate buffer
pH 3.5 and isopropanol in ratio (25:55:20) at a ﬂow rate of 1.5 mL/min and detection was carried
out at 254 nm. HPLC method allowed good resolution between the peaks that corresponded to thermining
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Figure 1 Structures of clonazepam
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j.arabjc.2014.10.051active pharmaceutical ingredients and its degradation products with good linearity, precision,
accuracy, speciﬁcity, LOD and LOQ. The expanded uncertainty (0.33%) of the method was also
estimated from method validation data. This analytical technique is not only ecofriendly but also
faster than the conventional liquid chromatographic system ofﬁcial in the USP-36.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Due to scientiﬁc and public concern about the environment
pollution, environmentally friendly practices have been intro-
duced in different areas of society and research. In green ana-
lytical chemistry, sample preparation and LC analysis need
special attention because hazardous solvents are often used.
European medicine agency (EMA) mentioned that solvents
like methanol and tetrahydrofuran are ranked by as hazardous
solvents (ICH Topic Q3C (R4), 2009) and because of their
inherent toxicity, safe detoxiﬁcation of the waste solvents is
essential, which may lead to high to very high disposal costs.
Possibilities toward green LC include reducing solvent use,
switching to more benign solvents and/or eliminating organic
solvents (Armenta et al., 2008; Kerton and Marriott, 2013;
Taylor, 2010; Clark and Tavener, 2006). Clonazepam
[5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one]
is mainly used as anticonvulsant, muscle relaxant and anxio-
lytic agent. Clonazepam is slightly soluble in acetone,
chloroform, acetic anhydride, hardly soluble in methanol, iso-
propanol, ether, almost insoluble in water. In all of the afore-
mentioned LC techniques, including the USP-36 relevant
monograph, tetrahydrofuran and methanol have been used
as a part of mobile phase and extraction procedure. The pres-
ent investigation describes a rapid, accurate and precise RP-
HPLC method for the determination of Clonazepam and its
related compound A & B (Fig. 1) in pharmaceutical dosage
forms within quality control laboratories without the need to
use of hazardous, toxic solvents since this drug is being
marketed in domestic and international market.
2. Experimental
2.1. Materials and chemicals
USP – reference standard materials of clonazepam (99.88%),
related compound A and related compound B in addition to
excipient used for preparing the placebo were kindly providedand its related compounds (a) clo
et al., Applying green analytical chemist
rmaceutical formulations and calculatinby Sigma pharmaceutical industries (Egypt). All solvents and
reagents were of HPLC grade, and were purchased from
Sigma-Aldrich. HPLC grade water was obtained through a
Milli-Q system (Millipore, Milford, USA) and was used to pre-
pare all solutions.
Commercial samples of clonazepam tablets, manufactured
by Sigma pharmaceutical industries – Egypt, were used in
the applications.
2.2. Apparatus
Shimadzu HPLC system (Shimadzu, Kyoto, Japan), set to
recycle the mobile phase and was equipped with a System Con-
troller CBM-20A, Solvent Delivery Unit LC-20A, On-line
Degassing Unit DGU-20A, and Photo-diode Array detector
SPD-M20A. The peak areas were integrated automatically
by computer using a Shimadzu LC solution V1.24 SP1 soft-
ware program. A 20 lL volume of sample was introduced into
Auto-Sampler SIL-20A injector. Photo cabinet ‘‘Atlas Suntest
CPS Plus’’ – Germany has been used for photodegradation.
2.3. Analytical procedures
2.3.1. Reference method
According to the relevant monograph in the USP-36 (USP,
2013) the elution was carried out on a BDS C8 Hypersil column
(150 mm · 4.6 mm, 5 lm particle size) from Thermo scientiﬁc
(Massachusetts, USA). All analyses were performed at ambient
temperature under isocratic conditions with a mobile phase of
ammonium phosphate buffer solution pH 8.0: methanol: tetra-
hydrofuran at a ﬂow rate of 1.5 mL/min in ration (60:52:13,
v/v), using UV detection at 254 nm. Diluent solution prepared
by mixing water, methanol, and tetrahydrofuran in ration
60:52:13 was used for standard and sample preparation.
2.3.2. Proposed liquid chromatography method
2.3.2.1. Preparation of stock solutions and standards. Stock
standard solution of clonazepam, related compound A andnazepam (b) clonazepam related A and (c) clonazepam related B.
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centration of 0.2 mg/ml. Series of dilutions at concentration
levels of 4–140 lg/mL were obtained from stock solution by
the appropriate dilution in mobile phase.
2.3.2.2. Sample preparation. Samples, of randomly selected clo-
nazepam tablets, were dissolved and diluted to the appropriate
volumes to get a concentration of 0.04 mg/ml using mobile
phase as solvent. All samples were ﬁltered through nylon
sample ﬁlter (Whatman, 0.22 lm).
2.3.2.3. Method development and chromatographic conditions. A
variety of mobile phases were investigated in the development
of a stability-indicating HPLC method for the analysis of clo-
nazepam and its related compound in pharmaceutical prepara-
tions. The suitability of mobile phase was decided on the basis
of green analytical chemistry principles, selectivity, sensitivity
of the assay, stability studies, and separation of clonazepam
from the known related substances (A&B) beside the impuri-
ties formed during forced degradation studies. The elution
was carried out on a BDS C8 Hypersil column
(250 mm · 4.6 mm, 5 lm particle size) from Thermo scientiﬁc
(Massachusetts, USA). All analyses were performed at ambi-
ent temperature under isocratic conditions with a mobile phase
of isopropanol: 2% sodium dodecyl sulfate (SDS): 0.05 M
sodium acetate buffer (pH 3.5 ± 0.05) in ratio (20:25:55, v/v)
at a ﬂow rate of 1.5 mL/min, using DAD detector at 254 nm.
2.3.2.4. Stability indicating capabilities of the proposed method.
The stability-indicating capability of the method was deter-
mined by its ability to separate the reference degradation sub-
stances (A&B) from the drug of interest in addition to
subjecting reference solution of clonazepam (40 lg/mL) to
forced degradation conditions by acidic, basic, oxidative, and
photolytic conditions to evaluate the interferences in the quan-
titation of clonazepam. Standard solutions in 1 M hydrochlo-
ric acid and 1 M sodium hydroxide were used for the acidic
and basic hydrolysis, respectively. Both solutions were kept
at ambient temperature for 12 h. For oxidative degradation,
solutions were prepared in hydrogen peroxide (3%) solution
and kept at ambient temperature for 4 h. Photodegradation
was induced by irradiating the neutral solution at 1.2 million
lux hours for 24 h. The distance between the light source and
the sample was maintained at 25 cm. These solutions were
diluted with mobile phase to ﬁnal concentration of 40 lg/ml
and were injected into chromatographic system.
2.3.2.5. Linearity. Linearity was evaluated by determining the
response of a series of dilutions of thirteen standard solutions
from clonazepam and nine standard solutions of its related
compounds (A&B) at a concentration range of 4–140 lg/mL
and 4–64 lg/mL, respectively. Each dilution was injected in
triplicate to plot the calibration curve. Slope, intercept, and
regression coefﬁcient (R2) of the calibration curves were calcu-
lated to ascertain linearity of the method.
2.3.2.6. Precision. For method repeatability, assay of authentic
samples solutions was repeatedly performed six times on the
same day (intra-day). For reproducibility, freshly prepared
solutions at aforementioned concentration level were analyzed
at different days (inter-day), and results were statistically
evaluated in terms of % RSD. The authentic samples werePlease cite this article in press as: Eldin, A.B. et al., Applying green analytical chemist
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the related compounds (A&B) to the placebo. These samples
were handled as descried under assay preparation to give the
desired concentration.
2.3.2.7. Accuracy. Accuracy was calculated as the deviation of
the mean from nominal concentration. To assess accuracy,
freshly prepared placebo of the clonazepam pharmaceutical
formulations was spiked with various amounts of clonazepam
and its related compounds (A&B) to obtain the concentration
levels of 30, 40 and 50 lg/ml. Each solution was injected in
triplicate.
2.3.2.8. Limit of detection (LOD) and limit of quantitation
(LOQ). The LOD is taken as the lowest concentration of an
analyte in a sample that can be detected, but not necessarily
quantiﬁed, under the stated conditions of the test while the
LOQ is the lowest concentration of an analyte in a sample that
can be determined with acceptable precision and accuracy
under the stated conditions of test. They can be calculated
from the linear calibration curve where LOD is the 3 times
of residual standard deviation of the regression line (at the
lower concentration) divided by the slope, while LOD is ten
times the division product (Shrivastava and Gupta, 2011).
2.3.2.9. Robustness. In order to check the robustness, the effect
of small but deliberate variations in the chromatographic con-
ditions was evaluated. The conditions studied were ﬂow rate
(altered by ±0.01 mL/min), and pH of buffer solution (altered
by ±0.1). These chromatographic variations were evaluated
for retention time, peak area, number of theoretical plate
and asymmetry factor for each clonazepam and its related
compound.
2.3.2.10. Selectivity and system suitability. Selectivity of this
method was indicated by the absence of any excipient interfer-
ence at the retention times of the peaks of clonazepam and its
related compounds with an acceptable resolution in the system
suitability solution. The absence of interfering peak was eval-
uated by injecting a blank sample consisting of diluent and pla-
cebo. The test is only valid if the resolution between
clonazepam related A and clonazepam related B is more than
2 as stated in the relevant monograph in the USP 36 (USP,
2013).
2.3.2.11. Uncertainty of the method. Among the different
sources of uncertainty, the uncertainty associated with calibra-
tion appears to be the most important source in the overall
uncertainty (ICH guideline Q2B, 2005).
The quantiﬁcation of clonazepam by was assess through the
calibration curve equation (Y= aX+ b), where Y is the
response, a is the slope, X is the concentration of clonazepam
and b is the intercept. Based on this information, the uncer-
tainty of HPLC’s result was estimated by the following
equation:
UA% ¼ A% t1a=n2 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðrY þ rbÞ2
ðY bÞ2 þ
ra
a
 2s
where UA% is the expanded uncertainty, t1-a/n-2 is the t-stu-
dent for conﬁdence level of 1-a and n-2 degrees of freedom
(n correspond to the numbers of standard employed to obtainry (GAC) for development of stability indicating HPLC method for determining
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rY is the standard deviation of the areas obtained in chro-
matograms of sample, Y is the average of the areas obtained
in chromatograms of sample, rb is the error for the intercept
and ra is the error for the slope.
3. Results and discussions
3.1. Optimization of the chromatographic conditions
The HPLC procedure was optimized with a view to develop an
ecofriendly stability-indicating method. No internal standard
was used because no extraction or separation step wasFigure 2 Separation of system suitability solution using (a) the
proposed green method and (b) the USP-36 method (Clonazepam
at 9.84, related compound A at 14.86 and related compound B at
16.90) and (b) the USP-36 method (Clonazepam at 10.21, related
compound A at 21.41 and related compound B at 23.71).
Table 1 Linearity of calibration curve for clonazepam and its relat
Clonazepam Clonazepam related co
Concentration (lg/ml) Peak area Concentration (lg/ml)
4 354,436 4
8 714,285 8
16 1,438,491 16
24 2,153,360 24
32 2,880,450 32
40 3,594,755 40
48 4,323,766 48
56 5,042,151 56
64 5,775,803 64
80 7,304,113 R2
100 9,080,737 Slope
120 10,822,764 Intercept
140 12,556,717
R2 0.9999
Slope 90217
Intercept 231.86
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(Clark et al., 2006), various solvent systems as mobile phases
were tried for the development of a green and environmentally
benign HPLC method. Of several solvents and solvent mix-
tures investigated, the mobile phase of isopropanol: 2%
SDS: 0.05 M sodium acetate buffer (pH 3.5 ± 0.05) in ratio
(20:25:55, v/v) was found to furnish sharp, well deﬁned peaks
with very good symmetry (around 1) and appropriate separa-
tion (NLT 2) between the peak of interest and the related com-
pounds as a system suitability requirement in the relevant
monograph in the USP-36 (Fig. 2).
Other organic modiﬁers and surfactants were tried such as
Brij-L23, tween 20 and tween 80 did not resulted in chromato-
graphic system as good as proposed method.
3.2. Method validation
3.2.1. Linearity
The calibration curves of clonazepam, clonazepam related A
and clonazepam related B were evaluated by the linear least
square analysis. The calibration curve plotted between concen-
tration of drug and peak area and the regression equations
were calculated and the correlation coefﬁcients of the calibra-
tion curves were found to be R2 > 0.999 in all samples types.
Linearity was established in concentration range of 4–140 lg/
ml for clonazepam and 4–64 lg/ml for clonazepam related
compounds A & B as reported in Table 1. The linear regression
data for the calibration plot were indicative of a good linear
relationship between peak area and concentration over a wide
range. The correlation coefﬁcient was indicative of high signif-
icance. The intercept of the ordinate showed the calibration
plot did not deviate from linearity.
3.2.2. Accuracy
Accuracy was determined by the standard addition method.
Three sets of placebo preparations were spiked with 32, 40
and 48 lg/ml of clonazepam and related substances reference
standards and the mixtures were analyzed by the proposed
method. The experiment was performed in triplicate. Gooded substances.
mpound A Clonazepam related compound B
Peak area Concentration (lg/ml) Peak area
43,266 4 116,673
87,160 8 240,323
176,453 16 493,393
273,040 24 739,427
367,352 32 978,949
451,953 40 1,232,962
545,139 48 1,475,217
638,419 56 1,715,512
734,168 64 1,926,860
0.9998 R2 0.9997
11496.851 Slope 30429.064
4458.937 Intercept 3781.023
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Table 3 Repeatability and intermediate precision for clonazepam and its related substances.
Exp. No. Repeatability on day 1 Repeatability on day two
Clonazepam Related A Related B Clonazepam Related A Related B
1 99.90% 100.06% 100.92% 100.00% 100.16% 101.02%
2 99.93% 100.33% 101.16% 100.23% 100.63% 101.46%
3 99.96% 100.30% 100.99% 100.16% 100.50% 101.19%
4 99.97% 100.30% 101.76% 100.37% 100.70% 102.17%
5 99.79% 100.27% 101.91% 99.89% 100.37% 102.01%
6 99.93% 100.94% 101.65% 100.13% 101.14% 101.86%
Mean 99.91 100.37 101.40 100.13 100.58 101.62
SD 0.064 0.298 0.427 0.168 0.334 0.464
RSD (%) 0.064 0.297 0.421 0.168 0.332 0.456
Figure 3 Clonazepam solutions under basic degradation condi-
tions (Clonazepam at 9.28, basic degradation products at 10.52,
13.98, 19.34 and 20.73).
Figure 4 Clonazepam solution under acidic degradation condi-
tions (Clonazepam at 9.26, acidic degradation products at 10.50,
13.55, 19.47 and 20.74).
Table 2 Estimation of the accuracy as an item for validation of the proposed HPLC method for the determination of clonazepam and
its related substances.
Amount taken (lg) Amount found (lg) Percent recovery Mean percentage recovery RSD%
Clonazepam 32 31.87 99.59% 99.57% 0.11
40 39.78 99.45%
48 47.84 99.67%
Clonazepam related compound A 32 32.28 100.88% 99.77% 0.97
40 39.62 99.05%
48 47.71 99.40%
Clonazepam related compound B 32 32.16 100.50% 100.97% 0.42
40 40.53 101.33%
48 48.52 101.08%
Green analytical chemistry for development of HPLC method 5recoveries (101.33–99.40%) were obtained at each concentra-
tion level with a very low % RSD (0.97–0.11%) which indi-
cated the accuracy of the proposed method (Table 2).
3.2.3. Precision
3.2.3.1. Analysis repeatability. It was evaluated by carrying out
the analysis of the six homogenous solutions of same test sam-
ple and content of related substances. The determinations were
carried out one after the other under conditions as similar as
possible. The relative standard deviation was calculated from
the results of the obtained observations (Table 3).
3.2.3.2. Intermediate precision. The intermediate precision of
the method was checked by determining precision on a differ-
ent instrument, analysis being performed in different labora-
tory on a different day. The relative standard deviation was
calculated from the results of the obtained observations.
In all cases the RSD was lower than 2 (Table 3).
3.2.4. Speciﬁcity
The speciﬁcity of the method was evaluated through its ability
to discriminate between the peak of the parent drug and those
due to its related compounds A & B (Fig. 2).
In the same regard a forced degradation study was estab-
lished, clonazepam stock solution was exposed to various stress
conditions. On treating with 5 N NaOH extensive degradation
has been occurred, when treated with 1 N NaOH for one hour,
the height of peak was reduced and four new peaks of degrada-
tion products were observed (Fig. 3). Almost the same has been
happened on treating with 1 N HCl for one hour (Fig. 4).Please cite this article in press as: Eldin, A.B. et al., Applying green analytical chemistry (GAC) for development of stability indicating HPLC method for determining
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Figure 5 Clonazepam solution under oxidative degradation
conditions (Clonazepam at 9.27, oxidative degradation products
at 12.75 and 19.01).
Figure 6 Clonazepam solution under photo-irradiation condi-
tions (Clonazepam at 9.58, photo degradation product at 14.66).
6 A.B. Eldin et al.Clonazepam was found to degrade more rapidly in oxidative
conditions. Upon reﬂux with 30% hydrogen peroxide for 1 h,
peak height was reduced, with the appearance of two new deg-
radation peaks (Fig. 5). One degradation peak has been sepa-
rated with dramatic change in the peak of the parent drug
has been happened on exposing to photo-irradiation conditions
in photo cabinet (Fig. 6).The above results show the method is
stability indicating.Table 4 LOD, LOQ and system suitability parameters*.
Parameters Clonazepam Clonazepam
LOD (lg/ml) 0.024 0.386
LOQ (lg/ml) 0.0799 1.2875
Theoretical plates (h) 18625.64 8854.82
Tailing factor (T) 1.104 0.988
Resolution – 6.865
* LOD, limit of detection; LOQ, limit of quantitation.
Table 5 Evaluation of robustness of the proposed method.
Drug name Variations C
R
Clonazepam Change in buﬀer pH 9
Flow rate at 1.51 ml/min 9
Clonazepam related compound A Change in buﬀer pH 14
Flow rate at 1.51 ml/min 14
Clonazepam related compound B Change in buﬀer pH 16
Flow rate at 1.51 ml/min 16
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system suitability
Limit of detection (LOD) and the limit of quantitation (LOQ)
were calculated as 3 S.D. and 10 S.D. of the blank, respec-
tively, according to the treatment by Miller and Miller
(Sadeghi et al., 2013). Before injecting solutions, the column
was equilibrated for at least 20 min with the mobile phase.
Their values prove the sensitivity of the proposed method
and that it can be used for detection and quantiﬁcation of trace
amounts of clonazepam and its related compounds. The
obtained system suitability parameters were satisfactory
according to the relevant USP-36 monograph (Table 4).
3.2.6. Robustness
The robustness of an analytical procedure, as deﬁned by the
ICH refers to its capability to remain unaffected by small
and deliberate variations in method parameters (Potka et al.,
2013). Robustness was determined by recording the effect of
slight change on the separation conditions of buffer and pH.
Table 5 shows that the theoretical plates, tailing factor and res-
olution of clonazepam and its related substances are not chan-
ged signiﬁcantly which indicates the proper robustness of the
method.
3.2.7. Uncertainty estimation
The expanded uncertainty amount (0.33% at conﬁdence level of
95%), was estimated based on the error of the slope and the
intercept. Considering HPLC method, a six standard calibra-
tion curvemay decrease the uncertainty estimated, as it decrease
the t-student multiplier. Increasing the number of injections per
standard level may also contribute in the reduction of ﬁnal
uncertainty (De Melo Abreu et al., 2005; Lourenc¸o, 2012).
Other sources of uncertainties, e.g. uncertainties of volumetric
glassware, were not considered due to its non signiﬁcant contri-
bution into the total budget of the uncertainty.related compound A Clonazepam related compound B
0.357
1.1893
9570.59
1.032
2.815
hromatographic parameters
etention time Area Theoretical plates Asymmetry
.83 3594745 18620.52 1.103
.75 3594760 18624.83 1.102
.66 451943 8840.77 0.998
.56 451961 8857.94 1.009
.85 1232974 9511.48 1.026
.75 1232950 9514.59 1.031
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Samples of clonazepam 0.5 mg tablets (n= 6) were analyzed
for the parent drug and its related substances by this method
and the results showed a percent recovery of 100.1% and a
RSD of 0.60% for 6 replicates while the related substances
were within the accepted limits. The method was used for ana-
lyzing samples of the stability program of the drug product
also for analysis of raw materials samples which give results
between 99.6% and 100.2%.
4. Conclusion
The proposed RP-HPLC method is simple, selective, rapid,
accurate, precise, reproducible, robust, sensitive and stability
indicating. Therefore, the method was applied to the assay of
clonazepam in tablets dosage form. The method is also simple
in terms of sensitivity, use of an environmentally benign
mobile phase, simple extraction procedures, relatively lower
retention time and no internal standard is required. These
advantages make this method superior for the routine analysis
of clonazepam and its related substances in commercially
available formulations. The method could also be applied for
the prediction of shelf life in the stability studies of the men-
tioned formulations because it is having stability-indicating
properties. The replacement of widely-used hazard solvents
and chemicals with new, innocuous, and less toxic ones
provides environmentally benign alternatives to the more
hazardous chemicals and processes in the ﬁeld of drug/phar-
maceutical analysis. Finally, estimation of the uncertainty is
important fulﬁll one of the ISO 17025 requirements aiming
to guarantees the quality and reliability of the obtained results.Authors’ contribution
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